Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Zai Lab Ltd - ADR - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ZLAB
Nasdaq
2834
http://www.zailaboratory.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Zai Lab Ltd - ADR
Zai Lab Announces Upcoming Presentations at June Investor Conferences
- May 24th, 2022 11:30 am
Zai Lab Announces Change to Virtual 2022 Annual General Meeting of Shareholders to be Held on June 22, 2022
- May 20th, 2022 8:01 pm
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates
- May 11th, 2022 7:13 am
Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia
- May 5th, 2022 3:55 pm
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
- May 2nd, 2022 6:31 pm
Turning Point Therapeutics and Zai Lab Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study
- Apr 28th, 2022 11:30 am
Zai Lab and Turning Point Therapeutics Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study
- Apr 28th, 2022 11:30 am
Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company’s Independent Registered Public Accounting Firm
- Apr 21st, 2022 11:30 am
10 Biotech Stocks to Buy Today According to Kerr Neilson’s Platinum Asset Management
- Apr 20th, 2022 6:25 pm
Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022
- Apr 20th, 2022 11:30 am
Zai Lab Plants a Tree for Every Employee on Earth Day 2022
- Apr 19th, 2022 12:00 pm
10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
- Apr 14th, 2022 2:06 pm
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List
- Apr 13th, 2022 1:20 am
Should You Already Consider Disposing Your Zai Lab (ZLAB) Shares?
- Apr 6th, 2022 2:05 pm
Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
- Apr 6th, 2022 12:01 pm
Some Chinese Companies Find Workaround to Avoid U.S. Delisting
- Apr 5th, 2022 11:28 am
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework
- Apr 1st, 2022 6:28 pm
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
- Mar 28th, 2022 10:25 am
Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022
- Mar 23rd, 2022 11:30 am
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
- Mar 21st, 2022 12:00 am
Scroll